We are live on ! Find out more
PVLA

Palvella Therapeutics
PVLA

81 hedge funds and large institutions have $136M invested in Palvella Therapeutics in 2021 Q4 according to their latest regulatory filings, with 21 funds opening new positions, 20 increasing their positions, 22 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

736% more call options, than puts

Call options by funds: $903K | Put options by funds: $108K

50% more first-time investments, than exits

New positions opened: 21 | Existing positions closed: 14

8% more funds holding

Funds holding: 75 → 81 (+6)

0.02% more ownership

Funds ownership: 0.6% → 0.62% (+0.02%)

9% less repeat investments, than reductions

Existing positions increased: 20 | Existing positions reduced: 22

18% less capital invested

Capital invested by funds: $165M → $136M (-$29.2M)

Holders
81
Holders Change
+6
Holders Change %
+8%
% of All Funds
1.25%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
21
Increased
20
Reduced
22
Closed
14
Calls
$903K
Puts
$108K
Net Calls
+$795K
Net Calls Change
+$1.08M

Top Buyers

Rank Fund Capital Flow
1
WP
Woodline Partners
California
+$9.86M
2
Marshall Wace
Marshall Wace
United Kingdom
+$7.94M
3
GPP
Great Point Partners
Connecticut
+$6.2M
4
Assenagon Asset Management
Assenagon Asset Management
Luxembourg
+$4.62M
5
Bank of America
Bank of America
North Carolina
+$1.66M

Top Sellers

Rank Fund Capital Flow
1
Invesco
Invesco
Georgia
-$7.76M
2
Millennium Management
Millennium Management
New York
-$3.28M
3
Baird Financial Group
Baird Financial Group
Wisconsin
-$2.59M
4
EI
EAM Investors
California
-$1.49M
5
Morgan Stanley
Morgan Stanley
New York
-$1.46M
Name Holding Trade Value Shares
Change 		Change in
Stake
Acadian Asset Management
26
Acadian Asset Management
Massachusetts
$1.31M +$1.1M +3,437 +380%
RPAM
27
Rhenman & Partners Asset Management
Sweden
$1.18M – – –
Connor, Clark & Lunn Investment Management (CC&L)
28
Connor, Clark & Lunn Investment Management (CC&L)
British Columbia, Canada
$982K +$45.5K +142 +5%
CSS
29
Cubist Systematic Strategies
Connecticut
$960K -$714K -2,229 -41%
BNP Paribas Financial Markets
30
BNP Paribas Financial Markets
France
$946K +$998K +3,117 +28,336%
Dimensional Fund Advisors
31
Dimensional Fund Advisors
Texas
$887K -$10.9K -34 -1%
State Street
32
State Street
Massachusetts
$716K – – –
D.E. Shaw & Co
33
D.E. Shaw & Co
New York
$504K +$534K +1,667 New
HF
34
HRT Financial
New York
$491K +$521K +1,626 New
Cerity Partners
35
Cerity Partners
New York
$455K – – –
William Blair & Company
36
William Blair & Company
Illinois
$446K +$412K +1,287 +685%
Northern Trust
37
Northern Trust
Illinois
$422K -$8.65K -27 -2%
6CM
38
683 Capital Management
New York
$340K – – –
SSA
39
Schonfeld Strategic Advisors
New York
$338K +$358K +1,119 New
WE
40
Wealth Effects
Massachusetts
$330K +$349K +1,091 New
AGM
41
Alpine Global Management
New York
$295K +$312K +975 New
Barclays
42
Barclays
United Kingdom
$294K +$151K +470 +93%
OQS
43
Occudo Quantitative Strategies
Florida
$279K +$226K +707 +329%
OMC
44
Old Mission Capital
Illinois
$265K +$281K +876 New
Jane Street
45
Jane Street
New York
$261K +$149K +465 +117%
E
46
Ergoteles
New York
$257K +$273K +851 New
BFM
47
Boothbay Fund Management
New York
$246K – – –
Balyasny Asset Management
48
Balyasny Asset Management
Illinois
$218K +$231K +720 New
Franklin Resources
49
Franklin Resources
California
$167K +$177K +554 New
Group One Trading
50
Group One Trading
Illinois
$163K -$108K -337 -38%
1
2
3 4

PVLA Hedge Fund Activity: Q4 2021 in Review

81 of the 6,498 institutional investors tracked by Wall St. Rank reported a position in Palvella Therapeutics (PVLA) for Q4 2021, worth a combined $136M — down 18% from $165M a quarter earlier.

Buyers outnumbered sellers: 21 funds opened new PVLA positions and 14 closed out — a net gain of 7 holders — while 20 added to existing stakes and 22 trimmed.

The largest buyer was Woodline Partners, opening a new position worth an estimated $9.86M. The largest seller was Invesco, exiting entirely with an estimated $7.76M sold.

  • 81 institutional investors held Palvella Therapeutics (PVLA) as of Q4 2021, up from 75 in Q3 2021.
  • Funds reported $136M of Palvella Therapeutics stock for Q4 2021, down 18% quarter-over-quarter.
  • 21 funds opened new Palvella Therapeutics positions in Q4 2021 and 14 closed out, a net change of +7 holders.
  • The largest Palvella Therapeutics buyer in Q4 2021 was Woodline Partners, an estimated $9.86M added.
  • The largest Palvella Therapeutics seller in Q4 2021 was Invesco, an estimated $7.76M sold.

Based on aggregated 13F filings for Q4 2021.